Latest filing published 24 Feb 2017 for Oncopeptides AB, €72k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jakob Lindberg: trading record in brief
All filings by Jakob Lindberg on record concern Oncopeptides AB. In total, 2 filings cover trades dated from 22 February 2017 to 24 February 2017.
Every open-market trade on record is a purchase: 2 purchases worth €273k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 24 February 2017 came the latest disclosure, an open-market purchase for €72k in Oncopeptides AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jakob Lindberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,909 shares@ SEK 46.00ISIN SE0009414576FI:csv-2322175559bf3c53507aCanonical exit: 23 May 2017 (T+90)
- 45,000 shares@ SEK 42.46100.0% of flowISIN SE0009414576FI:csv-e6c963e10d18da6e5dcdCanonical exit: 25 May 2017 (T+90)
2 of 2 declarations